← All stocks

EyePoint, Inc.

EYPT Balanced
CIK 0001314102 #3169 in the set updated 18 Sep 2026
Bought (120 mo)
$121.08M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$131.44M
$1.47M on a plan · $6.93M straight out of an exercise
Sold at will
$123.04M
22 of 62 sales
Net
−$10.36M
−$1.96M against sales at will

By person

24 insiders · 117 transactions
1.3×

Jay Duker holds only 1.3 times base salary in stock. $922.03K of shares against $696.25K in salary for 2025.

Salary from the company's own proxy. The shares are what Jay Duker last reported holding, valued at $4.93, the price Common Stock was last bought or sold at on the open market here, on 18 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Cormorant Asset Management, LP entity
Former 10% Owner
$89.50M (24)
$942.24K (1)
+$88.55M
8,265,000
9.59%
$40.75M
+134.1%
Liu Ye
Director
$56.67M (4)
−$56.67M
100,221
0.1162%
$494.09K
−96.7%
Ocumension Therapeutics
Director
$56.67M (3)
−$56.67M
100,221
0.1162%
$494.09K
−96.7%
EW Healthcare Partners, L.P. entity
10% owner
$30.80M (4)
$8.56M (13)
+$22.24M
54,431,701
63.14%
$268.35M
+83.5%
Paggiarino Dario A.
Chief Medical Officer
$2.88M (12) scheduled
−$2.88M
67,080
0.0778%
$330.70K
Jones David Scott
SVP & Chief Commercial Officer
$1.76M (11) scheduled
−$1.76M
44,916
0.0521%
$221.44K
Lurker Nancy
Director
$279.24K (4)
$1.64M (7) scheduled
−$1.36M
421,235
0.4886%
$2.08M
Pine Michael Craig
Chief Corp Dev.&Strat. Officer
$12.21K (1)
$990.00K (1) scheduled
−$977.79K
13,662
0.0158%
$67.35K
+308.7%
Ribeiro Ramiro
Chief Medical Officer
$948.77K (7) scheduled
−$948.77K
0
0.0000%
$0.00
−100.0%
GUYER DAVID R
Director
$383.74K (3) scheduled
−$383.74K
1,850
0.0021%
$9.12K
Zaderej Karen L.
Director
$265.46K (6)
+$265.46K
49,100
0.0570%
$242.06K
Landis John B.
Director
$69.60K (1)
+$69.60K
21,400
0.0248%
$105.50K
ANDO GORAN
Director
$39.75K (1)
+$39.75K
13,150
0.0153%
$64.83K
Elston George
Chief Financial Officer
$34.80K (4)
+$34.80K
97,470
0.1131%
$480.53K
Godshall Douglas Evan
Director
$29.78K (1)
+$29.78K
8,016
0.0093%
$39.52K
Duker Jay S.
President and CEO
$29.17K (2)
+$29.17K
187,025
0.2169%
$922.03K
+390.2%
DICICCO WENDY F
Director
$20.00K (1)
+$20.00K
9,967
0.0116%
$49.14K
Eastman Ronald W
Director
8,606,324
9.98%
$42.43M
0.0%
Mazzo David J
Director
200,083
0.2321%
$986.41K
+39,917%
ROGERS MICHAEL W
Director
119,167
0.1382%
$587.49K
Ross Leonard S
See Remarks
90,044
0.1044%
$443.92K
Barry James J
Director
12,500
0.0145%
$61.63K
Peterson Kristine
Director
6,667
0.0077%
$32.87K
ADAMIS ANTHONY P
Director
4,000
0.0046%
$19.72K
Insider
Date
Role
Action
Shares
Price
Amount
Mazzo David J
9 Oct 2019
Director
Exercised, kept
33,333
$1.95
$65.00K
Duker Jay S.
12 Apr 2019
Director
Exercised, kept
20,000
$1.77
$35.40K
Ross Leonard S
1 Apr 2019
See Remarks
Exercised, kept
5,000
$1.81
$9.05K
Mazzo David J
29 Mar 2019
Director
Exercised, kept
20,000
$1.77
$35.40K
ROGERS MICHAEL W
15 Nov 2018
Director
Exercised, kept
100,000
$1.13
$113.00K
Mazzo David J
20 Apr 2018
Director
Exercised, kept
120,000
$1.13
$135.60K

What was left out

Form 4 filings counted 313
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 33
Sales at will 22
Transactions with no price 0
Shares from compensation/vesting 3,676,102
Sales filed before the plan box existed 1
History held since 4 Nov 2016